Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D09TQP
|
|||
| Former ID |
DNC006802
|
|||
| Drug Name |
3-phenyl-1,4-dihydroindeno[1,2-c]pyrazole
|
|||
| Synonyms |
3-phenyl-1,4-dihydroindeno[1,2-c]pyrazole; CHEMBL215971; SCHEMBL6968182; NZNCUNCNFCUBOK-UHFFFAOYSA-N; BDBM50188284; ZINC36338882
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C16H12N2
|
|||
| Canonical SMILES |
C1C2=CC=CC=C2C3=C1C(=NN3)C4=CC=CC=C4
|
|||
| InChI |
1S/C16H12N2/c1-2-6-11(7-3-1)15-14-10-12-8-4-5-9-13(12)16(14)18-17-15/h1-9H,10H2,(H,17,18)
|
|||
| InChIKey |
NZNCUNCNFCUBOK-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Hit-to-lead optimization of 1,4-dihydroindeno[1,2-c]pyrazoles as a novel class of KDR kinase inhibitors. Bioorg Med Chem Lett. 2006 Aug 15;16(16):4371-5. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.